NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
64 hedge funds and large institutions have $21.4M invested in Northwest Biotherapeutics, Inc. Common stock in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 26 closing their positions.
Holders
64
Holders Change
-10
Holders Change %
-13.51%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
12
Reduced
20
Closed
26
Calls
$132K
Puts
$347K
Net Calls
-$215K
Net Calls Change
+$100K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$268K |
| 2 |
2
Goldman Sachs
New York
|
$557K |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$247K |
| 4 |
4
Renaissance Technologies
New York
|
$495K |
| 5 |
CS
5
Credit Suisse
Zurich,
Switzerland
|
$1.24M |
